Articles by Daniel Marsh
Nifty Edges Up as Auto Gains Offset IT, FMCG Weakness; Oil Slide Aids Rupee
Indian equities were mixed on Thursday with Nifty up 0.08% and Sensex down 0.03%, as auto stocks rallied on lower oil prices, while IT and FMCG sectors fell.
Middle Eastern Penny Stocks Gain Attention as Regional Markets Rally
Middle Eastern penny stocks are drawing investor interest as regional markets rally, with Dubai leading gains and Egypt hitting record highs.
Alaska Air $500M Debt Sale Highlights War-Driven Fuel Cost Squeeze
Alaska Air Group issued $500M in senior notes to offset soaring jet fuel costs caused by the Iran war, joining American and JetBlue in tapping debt markets.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.
NANO Nuclear Soars on Supermicro Pact for AI Data Center Power
NANO Nuclear Energy shares jumped 24.6% after announcing a non-binding MOU with Super Micro Computer to explore powering AI data centers with microreactors. No final contracts or reactor approvals have been secured yet.
Ernexa Therapeutics Surges 60% on Promising Ovarian Cancer Preclinical Data
Ernexa Therapeutics shares jumped about 60% after the company announced its ERNA-101 cell therapy plus PD-1 blockade eliminated tumors and achieved 100% long-term survival in preclinical ovarian cancer models.
UnitedHealth Eases Prior Authorization Rules; UNH Shares Gain
UnitedHealth Group shares climbed 1% after the company announced it will eliminate prior authorization for 30% of services by 2026, including outpatient surgeries and diagnostic tests.
Avalo Therapeutics Soars 34% on $375M Offering Following Positive Phase 2 HS Data
Avalo Therapeutics shares surged 34% after pricing a $375M public offering, following positive Phase 2 results for abdakibart in hidradenitis suppurativa. The company aims to fund Phase 3 development.
Intel's AI-Driven Surge Faces Pivotal Test as AMD's Forecast and Apple Talks Lift Chip Sector
Intel shares rose 6% premarket after AMD's bullish forecast and Apple's reported chipmaking talks. Data Center and AI revenue grew 22%, but net losses and stretched valuation raise questions.